Schattenberg JM, Pares A, Kowdley KV, Heneghan MA, et al. A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA. J Hepatol 2021 Jan 20. pii: S0168-8278(21)00022.
PMID: 33484775